The market shift toward value-based care presents unprecedented opportunities and challenges for the US health care system. Instead of rewarding volume, new
value-based payment models reward better results in terms of cost, quality, and outcome measures. These largely untested models have the potential to upend health care stakeholders’ traditional patient care and business models.
In recent years, medical device manufacturers have embarked on an acquisition binge. We’ve seen a series of blockbuster deals as well as numerous smaller transactions. This M&A bonanza has been sparked in part by the belief that absolute scale creates competitive advantage.
But does it? In many other industries, we find a clear correlation between overall scale and profitability. Classic strategy has long focused on building scale because larger companies tend to wield more influence with customers and have a greater ability to maintain pricing discipline. They also benefit from the most accumulated experience with driving down costs and can spread costs over the widest base of business.
Yet in medtech, the correlation between industry scale and profitability is quite weak. Instead, Bain research shows that profitability is more a function of category leadership than overall scale.
Provides an overview of various ACO models existing in U.S. healthcare, their evolution and performance over last 5-6 years and provide a perspective on each of the model
The Biggest Healthcare Trends of 2019 and What's to Come in 2020Health Catalyst
In our Healthcare Outlook for 2019 webinar, Stephen Grossbart, PhD, and Bobbi Brown, MBA, shared their predictions for the biggest trends of the year. Which predictions panned out and which didn’t? View this webinar as Stephen takes a look back at 2019 and makes his forecast for 2020.
So, what did happen in 2019? Following the 2018 midterm elections, we predicted a divided Congress would not pass policies to strengthen or weaken the Affordable Care Act (ACA). We were right. Meanwhile, Democratic presidential candidates debated the extent to which they would support Medicare for All. Insurance costs continued to rise, breaking $20,000 annually for families with employer-sponsored coverage, and CMS continued to support payment policies rewarding quality and interoperability as part of their payment policy.
Join Stephen as he looks in the rearview mirror at these important issues and how they impacted the healthcare industry in 2019 and then gazes into the crystal ball to predict the trends that will most impact healthcare in 2020. In this webinar, Stephen discusses the following topics and more:
• The continued focus on price transparency.
• Congress’ efforts to control prescription drug costs.
• Policies that may change the future of ACOs.
• What to expect going into the 2020 election year.
The market shift toward value-based care presents unprecedented opportunities and challenges for the US health care system. Instead of rewarding volume, new
value-based payment models reward better results in terms of cost, quality, and outcome measures. These largely untested models have the potential to upend health care stakeholders’ traditional patient care and business models.
In recent years, medical device manufacturers have embarked on an acquisition binge. We’ve seen a series of blockbuster deals as well as numerous smaller transactions. This M&A bonanza has been sparked in part by the belief that absolute scale creates competitive advantage.
But does it? In many other industries, we find a clear correlation between overall scale and profitability. Classic strategy has long focused on building scale because larger companies tend to wield more influence with customers and have a greater ability to maintain pricing discipline. They also benefit from the most accumulated experience with driving down costs and can spread costs over the widest base of business.
Yet in medtech, the correlation between industry scale and profitability is quite weak. Instead, Bain research shows that profitability is more a function of category leadership than overall scale.
Provides an overview of various ACO models existing in U.S. healthcare, their evolution and performance over last 5-6 years and provide a perspective on each of the model
The Biggest Healthcare Trends of 2019 and What's to Come in 2020Health Catalyst
In our Healthcare Outlook for 2019 webinar, Stephen Grossbart, PhD, and Bobbi Brown, MBA, shared their predictions for the biggest trends of the year. Which predictions panned out and which didn’t? View this webinar as Stephen takes a look back at 2019 and makes his forecast for 2020.
So, what did happen in 2019? Following the 2018 midterm elections, we predicted a divided Congress would not pass policies to strengthen or weaken the Affordable Care Act (ACA). We were right. Meanwhile, Democratic presidential candidates debated the extent to which they would support Medicare for All. Insurance costs continued to rise, breaking $20,000 annually for families with employer-sponsored coverage, and CMS continued to support payment policies rewarding quality and interoperability as part of their payment policy.
Join Stephen as he looks in the rearview mirror at these important issues and how they impacted the healthcare industry in 2019 and then gazes into the crystal ball to predict the trends that will most impact healthcare in 2020. In this webinar, Stephen discusses the following topics and more:
• The continued focus on price transparency.
• Congress’ efforts to control prescription drug costs.
• Policies that may change the future of ACOs.
• What to expect going into the 2020 election year.
With the patient at the true center of next generation care, it is critical to stay on the cutting edge of what is required for compliance monitoring, particularly for specialty products. With a focus on patient interactions and associated programs, this Helio presentation highlights how the automation of a company's compliance monitoring and implementation of an analytics engine can produce real-time results and identify best practices to be applied to business intelligence for future activities.
PYA Highlights Next Steps of Meaningful UsePYA, P.C.
At the 2013 AICPA Healthcare Industry Conference, PYA Principal David McMillan and Senior Manager Chris Wilson recently explored the “new normal” of meaningful use as compliance and strategic standards in new care/reimbursement-model development.
The Fourth Industrial Revolution will permanently change how medical device companies do business. Historically, the medical device industry has created tremendous value via the creation of therapeutic devices. It is now time for the industry to invest more effort in analytics-based solutions that enable seamless, real-time care management.
Top Healthcare and Revenue Cycle Trends to watch for in 2019Manish Jain
2017 required healthcare organizations to respond to several new challenges – political change, growing role of technology, shift to value-based care and the increasing role of information security. While we anticipate that these issues will continue to influence through 2018, we will also see new challenges. The blurring lines between providers and payers, a refocusing on care (and more so on the patient), and a changing policy environment will occupy the center stage for 2018.
Historically, the medical device industry has been highly attractive and relatively stable. As a consequence, established players have been able to compete successfully across the device spectrum, applying common business models and processes without much need for differentiation.
The future, however, is very different as disruptive change is underway. Companies will need to look at new segments and offer end-to-end solutions to secure additional revenue and maintain their profit margins.
Learn about 2016 trends in government and private healthcare spending, employer costs, and the patient-as-consumer movement that's spurring new provider models.
PYA Thought Leader Defines Role of Radiation Oncology in Clinical IntegrationPYA, P.C.
PYA Senior Consulting Manager Chris Wilson presented “Clinically Integrated Networks (CIN) and the Role for Radiation Oncology” at the SATRO® 16 Conference, April 24-25, 2014, at the Crowne Plaza Ravinia in Atlanta, Georgia.
Key Takeaways from the first IDC Pan European Healthcare Summit . Post event ...Silvia Piai
This slide deck summarizes the key takeaways from the first Pan European Healthcare Executive Event. Focused on the three themes of the Summit ( Personalization,Integration and Industrialization), the Summit has explored the different dimensions in which ICT is an enabler of a new business model for sustainable healthcare in Europe
In his October 2, 2015 keynote address to the Florida Association of Accountable Care Organizations (FLAACOs) Fall conference in Orlando, GuideWell's President, René Lerer, M.D., shared how the organization has implemented ACO and other arrangements all intended to deliver on the Triple Aim. Visit http://www.guidewell.com/ for more information.
White Paper - Digital strategy and the shift to value based careTerence Maytin
Summary: The U.S. healthcare system is rapidly transitioning from fee-for-service to value- based care as part of massive and ongoing industry-wide transformation. Digital strategy is evolving to meet new challenges, help drive disruptive innovation, and better engage a large, growing audience of connected health consumers.
The Foundations of Success in Population Health ManagementHealth Catalyst
From hospital systems to large employers, organizations are increasingly taking on financial risk for the health of populations. Drivers of this trend include the update to the MSSP model, the recent CMS Primary Cares Initiative announcement, the increasing prevalence of the Medicare Advantage model, innovative partnerships in the self-insured employer space, and the proliferation of Medicaid ACOs. Yet while market pressures push organizations toward population risk, they don't necessarily help them succeed: most organizations are struggling to attain or sustain the dual imperatives of high-quality care and cost containment. A primary reason? Short-sighted and tactical approaches that don't provide the flexible data infrastructure and tools to adapt to emerging trends in population health—or to support short-term contractual requirements while building toward long-term success.
View this launch webinar to learn about Health Catalyst’s Population Health Foundations solution, a data and analytics-first starter set aimed at optimizing performance in value-based risk arrangements and providing the data ecosystem that will flex and adapt to complex needs of risk-bearing organizations. Solution services ensure that the strategic value of data is maximized to improve performance in risk contracts—and provide side-by-side subject matter expert partnership for establishing short- and long-term goals for population health management (PHM).
Built on Health Catalyst’s foundational technology and supported by the nationwide experience and perspective of its experts, the Population Health Foundations solution helps organizations leverage multiple data sources to understand their patient populations and create meaningful views of financial and clinical quality performance. As a starter set that organizations can build on based on their needs, the solution is designed to compensate for the known limitations of “black box” population health applications that fail to reveal the “why” of analytic insights and exacerbate the challenges of transforming quality, cost, and care. The Population Health Foundations solution delivers the essential analytic tools needed for success under value-based risk arrangements.
In these slides you can expect to:
- Review recent changes to the field of value-based care, and reactions and insights from the market
- Discover how the Population Health Foundations solution can act as a comprehensive, data-first analytics solution to support your population stratification and monitoring needs
- Understand how this solution functions as a foundational starter set for value-based care success, enabling clients to leverage all their data and other relevant population health tools
Payers are being challenged as the industry shifts from volume-based care to a value-based reimbursement structure that would benefit the patient, the healthcare provider and the payer. New payment models including fee-for-service only and pay-for performance creates impetus for payers to acquire, aggregate, and analyze data.
With the patient at the true center of next generation care, it is critical to stay on the cutting edge of what is required for compliance monitoring, particularly for specialty products. With a focus on patient interactions and associated programs, this Helio presentation highlights how the automation of a company's compliance monitoring and implementation of an analytics engine can produce real-time results and identify best practices to be applied to business intelligence for future activities.
PYA Highlights Next Steps of Meaningful UsePYA, P.C.
At the 2013 AICPA Healthcare Industry Conference, PYA Principal David McMillan and Senior Manager Chris Wilson recently explored the “new normal” of meaningful use as compliance and strategic standards in new care/reimbursement-model development.
The Fourth Industrial Revolution will permanently change how medical device companies do business. Historically, the medical device industry has created tremendous value via the creation of therapeutic devices. It is now time for the industry to invest more effort in analytics-based solutions that enable seamless, real-time care management.
Top Healthcare and Revenue Cycle Trends to watch for in 2019Manish Jain
2017 required healthcare organizations to respond to several new challenges – political change, growing role of technology, shift to value-based care and the increasing role of information security. While we anticipate that these issues will continue to influence through 2018, we will also see new challenges. The blurring lines between providers and payers, a refocusing on care (and more so on the patient), and a changing policy environment will occupy the center stage for 2018.
Historically, the medical device industry has been highly attractive and relatively stable. As a consequence, established players have been able to compete successfully across the device spectrum, applying common business models and processes without much need for differentiation.
The future, however, is very different as disruptive change is underway. Companies will need to look at new segments and offer end-to-end solutions to secure additional revenue and maintain their profit margins.
Learn about 2016 trends in government and private healthcare spending, employer costs, and the patient-as-consumer movement that's spurring new provider models.
PYA Thought Leader Defines Role of Radiation Oncology in Clinical IntegrationPYA, P.C.
PYA Senior Consulting Manager Chris Wilson presented “Clinically Integrated Networks (CIN) and the Role for Radiation Oncology” at the SATRO® 16 Conference, April 24-25, 2014, at the Crowne Plaza Ravinia in Atlanta, Georgia.
Key Takeaways from the first IDC Pan European Healthcare Summit . Post event ...Silvia Piai
This slide deck summarizes the key takeaways from the first Pan European Healthcare Executive Event. Focused on the three themes of the Summit ( Personalization,Integration and Industrialization), the Summit has explored the different dimensions in which ICT is an enabler of a new business model for sustainable healthcare in Europe
In his October 2, 2015 keynote address to the Florida Association of Accountable Care Organizations (FLAACOs) Fall conference in Orlando, GuideWell's President, René Lerer, M.D., shared how the organization has implemented ACO and other arrangements all intended to deliver on the Triple Aim. Visit http://www.guidewell.com/ for more information.
White Paper - Digital strategy and the shift to value based careTerence Maytin
Summary: The U.S. healthcare system is rapidly transitioning from fee-for-service to value- based care as part of massive and ongoing industry-wide transformation. Digital strategy is evolving to meet new challenges, help drive disruptive innovation, and better engage a large, growing audience of connected health consumers.
The Foundations of Success in Population Health ManagementHealth Catalyst
From hospital systems to large employers, organizations are increasingly taking on financial risk for the health of populations. Drivers of this trend include the update to the MSSP model, the recent CMS Primary Cares Initiative announcement, the increasing prevalence of the Medicare Advantage model, innovative partnerships in the self-insured employer space, and the proliferation of Medicaid ACOs. Yet while market pressures push organizations toward population risk, they don't necessarily help them succeed: most organizations are struggling to attain or sustain the dual imperatives of high-quality care and cost containment. A primary reason? Short-sighted and tactical approaches that don't provide the flexible data infrastructure and tools to adapt to emerging trends in population health—or to support short-term contractual requirements while building toward long-term success.
View this launch webinar to learn about Health Catalyst’s Population Health Foundations solution, a data and analytics-first starter set aimed at optimizing performance in value-based risk arrangements and providing the data ecosystem that will flex and adapt to complex needs of risk-bearing organizations. Solution services ensure that the strategic value of data is maximized to improve performance in risk contracts—and provide side-by-side subject matter expert partnership for establishing short- and long-term goals for population health management (PHM).
Built on Health Catalyst’s foundational technology and supported by the nationwide experience and perspective of its experts, the Population Health Foundations solution helps organizations leverage multiple data sources to understand their patient populations and create meaningful views of financial and clinical quality performance. As a starter set that organizations can build on based on their needs, the solution is designed to compensate for the known limitations of “black box” population health applications that fail to reveal the “why” of analytic insights and exacerbate the challenges of transforming quality, cost, and care. The Population Health Foundations solution delivers the essential analytic tools needed for success under value-based risk arrangements.
In these slides you can expect to:
- Review recent changes to the field of value-based care, and reactions and insights from the market
- Discover how the Population Health Foundations solution can act as a comprehensive, data-first analytics solution to support your population stratification and monitoring needs
- Understand how this solution functions as a foundational starter set for value-based care success, enabling clients to leverage all their data and other relevant population health tools
Payers are being challenged as the industry shifts from volume-based care to a value-based reimbursement structure that would benefit the patient, the healthcare provider and the payer. New payment models including fee-for-service only and pay-for performance creates impetus for payers to acquire, aggregate, and analyze data.
2016 IBM Interconnect - medical devices transformationElizabeth Koumpan
Emerging technologies such as Internet of Things, 3D Printing are driving the creation of new business models and forcing the Industry for transformation. The product centric model where the Industry main objective was to develop the device, is moving to software and services model, with the focus on Big Data & Analytics, Integration and Cloud.
The maturation of technologies such as social, mobile, analytics, cloud, 3D printing, bio- and nanotechnology are rapidly shifting the competitive landscape. These emerging technologies create an environment that is connected and open, simple and intelligent, fast and scalable. Organizations must embrace disruptive technologies to drive innovation
Healthcare IT Services Insights - January 2016Duff & Phelps
This issue of Healthcare IT Insights details the increased use of predictive analytics in the healthcare industry to reduce costs and improve outcomes for patients and populations. Predictive analytics can address three categories that unnecessarily cost the healthcare delivery system in the U.S. approximately $350 billion annually: overtreatment, care delivery failure and lack of care coordination.
Harness Your Clinical and Financial Data with an Enterprise Health Informat...Perficient, Inc.
The importance of Enterprise Health Information Exchange (EHIE) as a key way to empower your physicians and patients and demonstrate meaningful use of electronic health records:
- Present the business case for EHIE as an important architecture that matters to progressive health systems
- Take a look at some of the market-leading EHIE architectures and products
- Provide real exam...ples of organizations that are using EHIE to improve their operations
Healthcare by Any Other Name - Centricity Business WhitepaperGE Healthcare - IT
Whether referred to as integrated healthcare or accountable care, the
current focus on new healthcare models is a reaction to long-standing
concerns around quality, cost, and efficiency. Many of these issues stem
from care delivery systems that have been:
• Directed more at episodic treatment than prevention and early intervention
• Fragmented rather than integrated and coordinated
• Focused on patient eligibility and billing rather than patient engagement
within and outside of the care setting
• Customized to the idiosyncrasies of individual facilities rather than
standardized across care sites
• Rewarded more for volume than for quality and cost outcomes
The resulting inefficiencies have made healthcare less effective, less safe,
and more costly than can be tolerated, particularly against the backdrop of
a challenging worldwide economy. The old dictum ‘if you provide healthcare,
they will pay’ no longer applies. Public payers, private payers, and regulatory
agencies are wielding both carrots and sticks to drive healthcare organizations
toward greater coordination, demonstrable quality, and measurable
cost control.
The consensus on what ails our health systems, as well as the availability
of new technologies, has led to the creation of new models of delivery,
such accountable care organizations and integrated health organizations.
By whatever name, these healthcare models are designed to promote
accountability and improve outcomes for the health of a defined population.
Healthcare providers are transitioning to more powerful population health man...Persivia Inc
Healthcare organizations are implementing Population Health Management Platforms with integrated healthcare company's claims, electronic health records, laboratory, social determinants of health (SDoH), and other relevant information. To perform successfully and offer value-based care with superior healthcare outcomes, such platforms also develop cost and system performance criteria based on Medicare and Medicaid data points.
Healthcare data and its impact upon the patient care decision process via accurate, real-time, reliable data from disparate sources is creating a digital health revolution. Data-driven healthcare is beginning to have a huge impact addressing the challenges of every provider, through efficient handling of huge volumes of patient care data.
Providers need to move towards real-time analytics that have become critical to demonstrate their quality of care, as reimbursement by government programs can be contingent upon how providers are measured in “Quality of Care”. For example, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, also called the Permanent Doc Fix, changes the way Medicare doctors are reimbursed with the implementation of a merit based incentive. The performance-based pressure is huge, which makes it imperative that every provider consider technology solutions. Read more at https://www.solix.com/solutions/data-driven-solutions/healthcare/
Early Valuation for Entrepreneurs by John ShumatePlatform Houston
Early Valuation for Entrepreneurs by John Shumate
John Shumate is CEO of ValuLogik and has focused his career on working closely with venture-backed companies. He has worked with hundreds of early- and growth-stage companies across many industries, many of them dealing with highly-technical products or business models. He believes strongly in the use of carefully-applied rigor to rationalize financial models, business plans, valuations, and other quantification tools. He has over a decade of financial experience, including buy-side and sell-side mergers and acquisitions; debt and equity capital raises; strategic consulting; complex financial modeling; business plan development; equity and derivative valuation; and venture incubation. John recently served as Vice President at Blue Equity, a growth-stage private equity firm, and Chief Financial Officer at BellaNovus, an early-stage medical device development company. He was a Senior Associate at bCatalyst, a business incubator and financial services provider to early-stage companies. He has also held analytical roles for Ethicon-Endo Surgery, a division of Johnson & Johnson, and Hilliard-Lyons, a regional brokerage house. John attended the Wharton School at the University of Pennsylvania, where he received a B.S. in Economics and dual concentrations in Finance and Management
About Brian Meece
Brian Meece plays a mean ukulele and is the CEO of RocketHub, one of the world's top crowdfunding platforms. He has lectured on crowdfunding at SXSW, TEDxBrooklyn, Columbia University, Makers Faire, among other colleges, conferences and institutions. His goal? To teach creative entrepreneurs how to leverage the crowd for funding their endeavors.
About RocketHub
RocketHub is known as The World's Crowdfunding Machine. The company has been featured in the Wall Street Journal, The New York Times, Variety, Rolling Stone, NPR, Wired, The Economist, CNN, The Washington Post, ABC News, USA Today, etc. while helping thousands of funding campaigns raise millions of dollars globally.
RocketHub has recently partnered with A&E Networks for Project Startup, which brings crowdfunding and the RocketHub community to A&E's wide audience.
Nicole Moss is an attorney with the law firm of Campbell & Riggs, P.C., where she focuses on taking startup companies from inception to liquidity, as well as other corporate matters including mergers and acquisitions and private securities transactions. Previous experience includes: serving as General Counsel to a small investment fund in Houston; advising private equity and venture capital clients in fund formation and M&A activities as an attorney in the Boston office of Weil, Gotshal & Manges LLP; and serving as marketing and programs manager at the Massachusetts Institute of Technology Entrepreneurship Center. Prior to that, Nicole founded and ran BluePrint, a provider of non-core services to startups in and around Boston and also recruited founding team and advisory board members for startups at Cambridge Incubator. Nicole is a guest lecturer for the Wolff Center for Entrepreneurship at the University of Houston. She is licensed in Texas and Massachusetts.
Nicole Moss is an attorney with the law firm of Campbell & Riggs, P.C., where she focuses on taking startup companies from inception to liquidity, as well as other corporate matters including mergers and acquisitions and private securities transactions. Previous experience includes: serving as General Counsel to a small investment fund in Houston; advising private equity and venture capital clients in fund formation and M&A activities as an attorney in the Boston office of Weil, Gotshal & Manges LLP; and serving as marketing and programs manager at the Massachusetts Institute of Technology Entrepreneurship Center. Prior to that, Nicole founded and ran BluePrint, a provider of non-core services to startups in and around Boston and also recruited founding team and advisory board members for startups at Cambridge Incubator. Nicole is a guest lecturer for the Wolff Center for Entrepreneurship at the University of Houston. She is licensed in Texas and Massachusetts.
Landmines for Entrepreneurs with Olivier Wenker, MD, MBA, DEAAPlatform Houston
About Dr. Olivier Wenker
Since 2001, Dr. Wenker is M. D. Anderson Cancer Center's Director of Technology Discovery. In this function, he has created a novel support mechanism for clinical and research faculty. The fund he manages created within a few years a multiple of 4 on value creation for the institution. Dr. Wenker also teaches entrepreneurship classes in collaboration with The University of Texas System.
Dr. Wenker started his career as an anesthesiologist in 1985. He is triple European board certified in anesthesiology, critical care medicine and emergency/disaster medicine and holds the title Professor of Anesthesiology. Dr. Wenker served many years as emergency/trauma physician on board rescue helicopters, ICU airplanes, ambulances, and emergency physician vehicles. He worked as a trauma field physician, rescue diver, disaster medicine triage and lead physician, and served many years as chief of a medical team for special police forces. He was involved in over 700 rescue missions. In 2004, Dr. Wenker earned a Master of Business Administration degree from the Jones Graduate School for Management at Rice University in Houston, Texas, receiving the prestigious Jones Award for Academic Excellence.
Dr. Wenker's special interests involve electronic publishing and the use of digital information for education. In 1996, he founded "Internet Scientific Publications, LLC." This online platform became the world's largest electronic medical publishing house. Approximately 15,000 daily readers enjoy the free medical content offered by the site. Dr. Wenker created and launched 64 online journals in the past nine years. He assembled over 1,000 international editors and reviewers and closely collaborates with over 60 editors-in-chief. For two consecutive years he won the esteemed ASA (American Society of Anesthesiologists) "Exceptional Merit for Outstanding Education in Anesthesia Award." In addition, he won over 20 awards for his online journals. Most recently he received the Golden Web Award presented by the International Association of Webmasters and Designers.
An Overview of the Texas and Houston Tech/Life Science Investment Activity by...Platform Houston
Stephen J. Banks is the Venture Partner at S3 Ventures. He is a pioneer in venture capital and life sciences. Banks has earned a distinctive track record in backing Kleiner Perkins and co-investing in several of its outstanding companies including Genentech, Hybritech, and Tandem. He he been involved in the formation of more than 30 new technology companies spun out of the Baylor College of Medicine including Lexicon, GeneMedicine, ForeFront, Triplex, PrimaCis, and Zonagen. Banks also established BCMT’s venture fund and led its Venture Advisory Board, consisting of prominent investors including Oxford Biosciences, Domain Associates, Versant, VenRock, EuclidSR, ARCH, J&J Development, and Polaris. He taught a graduate venture capital course at Rice University during the years 1992 to 2005. Mr. Banks holds an M.B.A. from the Harvard Business School and a B.S. in Physics from the Massachusetts' Institute of Technology.
Marketing Your Product - A Guide for Entrepreneurs by Pradeep AnandPlatform Houston
Pradeep Anand has been a keynote speaker at business workshops, conferences and meetings in North America, Speaking, educating and training have been integral to his consulting practice at Seeta Resources—helping CEOs and senior executives accelerate their firms’ revenue and margin growth.
He serves on the Advisory Board of the University of Houston's College of Technology and the Houston Technology Center. He is a founder and trustee of the IIT Alumni of Greater Houston.
Pradeep received his MBA from the University of Houston and his BS in Metallurgical Engineering from the Indian Institute of Technology (IIT), Bombay, India.
Bobby Talbott is the Managing Agent and Agency Owner of Iscential, Tomball location and the Bobby Talbott Agency. Mr. Talbott works in the areas of risk management and insurance and has over 19 years of industry knowledge. He holds a BS from Embry-Riddle Aeronautical University in Professional Aeronautics. He is a sponsor of the Houston Angel Network and a supporter of young entrepreneurs. His hobbies include spending time with his wife and six children, and he is an off-road motorcycle enthusiast.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
High Flyer Health IT Investments and Health IT Investment Trends
1. Healthcare Growth Partners, LLC 2014 All Rights ReservedCONFIDENTIAL
Health IT – “High Flyer” Investment Trends
May 2014
2. CONFIDENTIAL 2HEALTHCARE GROWTH PARTNERS
Where are we?
HITECH (2011-2017)
(HITECH): Install and
ensure the usage of
electronic medical
records and basic
communications
infrastructure with the
capability of collecting
and aggregating data
across care settings
ACA (2012-2020)
(ACA Implementation):
Lay the foundation for
reform with pilot risk-
based reimbursement
models that are
dependent on
outcomes, quality and
efficiency rather than
the volume of service
Value-Based (2015+)
(ACO/Bundled
Payment): Execute on a
streamlined system of
robust care
coordination and
population health to
maximize quality as
well as efficiency with
the goal of delivering
higher value
Personalized 20??
(Personalized
Medicine): Using big
data, quality reporting,
and genetic analytics,
optimize care and
medicine based on
individualized
characteristics and
genomics
3. CONFIDENTIAL 3HEALTHCARE GROWTH PARTNERS
Healthcare Stakeholders React to Cost, Access, and Quality Initiatives
Providers
• Direct Impact
• Risk-based
pilots
• Readmission
penalties
• Fraud scrutiny
• Quality
reporting
• ICD-10 (non-
ACA)
• Indirect
• Resource
constraints
• Consolidation
• Focus on care
continuum
Payers
• Direct Impact
• Public HIX
• Private HIX
• Rate hike caps
• MLR caps
• Medicaid
expansion
• Coverage
requirements
• Indirect
• Expanding
capabilities
Employers
• Direct Impact
• Insurance
requirements
(min
employees/
hours)
• Indirect
• Defined
benefits
• Private HIX
• Wellness
initiatives
Med-Pharm
• Direct Impact
• Higher taxes
• Comparative
effectiveness
• Sunshine Act
• Indirect
• Care
management
• Big data
• Genomics
• Personalized
medicine
Patients
• Direct Impact
• Greater
protections
(pre-existing
conditions,
denials, caps)
• Greater
coverage
• More choice
• Non-
discrimination
• Indirect
• Greater
Responsibility
Information Technology – Quality & Cost (aka, Value)
4. CONFIDENTIAL 4HEALTHCARE GROWTH PARTNERS
Volume to Value Driving the Trend
• Payer
• Disease
• Care-setting
• Treatment
• Today, 10% of
Patients
5. CONFIDENTIAL 5HEALTHCARE GROWTH PARTNERS
Volume to Value Key Stats
Shift reflects the introduction of a
series of accountable care pilots
developed by CMS over the last few
years—specifically, the Medicare
Shared Savings Program (MSSP) and
the Bundled Payments for Care
Improvement (BPCI) initiative.
It’s important to note that the # of
providers does not represent the # of
patients – only a fraction of patients
at the risk-contracted facilities will be
risk-based.
Around two-thirds of providers report generating more than 80% of their revenue from
standard fee-for-service contracts, and about half are still receiving more than 90% of
payments for patient care from such contracts.
65% of providers are contracting with commercial payers on new payment models, in
many cases in conjunction with Medicare’s risk-based payment initiatives.
(Source: The Advisory Board Company)
6. CONFIDENTIAL 6HEALTHCARE GROWTH PARTNERS
Volume to Value Transition
1. Payers: Orientation toward value (eg, risk) has been core to payers for
years, in the form of utilization management, disease management, and
cost containment.
2. Employers: As the cost burden explodes and with their place secured as a
stakeholder in healthcare, employers are expanding the role in care
management. This trend is coupled with built-in incentives from the ACA.
Further, employers can be more nimble in navigating FDA vs non-FDA
regulated mobile monitoring (eg, games, wellness platforms, etc).
3. Providers: As discussed, value is limited to narrow patient populations
based on payer, disease, and care program. IT and services that
complement value-based reimbursement must be consistent with
incentives.
4. Patients: The out-of-pocket financial burden is expanding (now 25%+ of
provider revenue and share is growing). For now, true patient care
decisions tend to be managed by the stakeholders above.
7. CONFIDENTIAL 7HEALTHCARE GROWTH PARTNERS
Changing Incentives = Changing Business Models
The Spreading Cost Burden
• Risk-based payment
• Readmission programs
• Higher patient pay
• De-centralized care
Phase 1 Technologies Phase 2 Technologies Phase 3 Technologies
The Marketplace Response
• Provider-focused
• EMR/RCM
• HIE
• Establishes the
“infrastructure”
• Data collection and sharing
• Employer Focus
and
• Population Health
• Care Coordination
• Data Analytics
• Risk Stratification
Providers
• Patient/Individual Focus
• Mobile apps
• Tele/Monitoring
• Personalized Medicine
• Predictive Analytics
• Data Optimization
Payers Employers Consumers
• MLR caps
• Premium caps
• HIX = “Consumer”
• Coverage expansion
• Comprise 40%+ of
healthcare spend
• ACA secured their
stakeholder status
• Higher patient pay
(25% is out-of-pocket)
• More (and less) choice
• Patient Engagement
8. CONFIDENTIAL 8HEALTHCARE GROWTH PARTNERS
Phase 3 Technologies Developments and Challenges
There have been tailwinds in the emergence of consumer-facing HIT technologies
• Proliferation of mobile technologies driven by advent of smart phones serve as a critical hub,
and accessibility of sensor innovation which provide real-time data insights
• Employers, payers, and even providers are subsidizing the cost of mobile technologies, either
directly (by purchasing on behalf of patients) or indirectly (by monetizing data or through ads)
…However, there remain some obstacles
• Reimbursement for Tele-Health and Remote Monitoring remains vague
• FDA and licensing ambiguity will stall growth and already lagging payer reimbursement trends
• Physicians and other care providers are often resistant to the disruption of remote or tele-
health
• Today, the market is responsive to very target reimbursement programs (eg, Readmission
Reduction Program), but these programs and risk-based payment models are expanding
9. CONFIDENTIAL 9HEALTHCARE GROWTH PARTNERS
Keys to Success
Valuation-Centric
1. Cloud technology (multi-tenant that enables scale and analytics)
2. For apps, developing a platform rather than an app
3. Open, accessible APIs
4. Recurring revenue model
Customer-Centric
1. Hard ROI
2. Pricing that aligns with Hard ROI (increase revenue or drive down cost)
3. Policy/Political alignment with Business Model (government, associations,
reimbursement, etc)
4. Non-disruptive or even enabler of clinical/admin/patient workflow
10. CONFIDENTIAL 10HEALTHCARE GROWTH PARTNERS
Reasons for Failure
1. Innovating too far ahead of the adoption curve
2. Misalignment with the healthcare incentive model
3. Lack of clinical/workflow understanding
4. Inappropriate revenue model
5. Inefficient distribution model (go-to-market plan)
6. Data/architecture “closed” (note, this used to be a key to success)
7. Ramping up too quickly – going too deep into the red
Lack of readiness for long sales cycle
8. Losing focus on customer happiness/retention
11. CONFIDENTIAL 11HEALTHCARE GROWTH PARTNERS
Trending Investment Verticals
Employer
Health
Benefits
Management
Health
Consumers
Patient
Engagement
Big DataPM & EMR
Remote Care
ACO Tools
ACO-Oriented
RCM
Guiding Theses
• Transparency
• Cost & Quality
• Big data
• Value-based payment
• Patient vs Consumer Engagement
• Informed, connected patient
• Utilization Management
• Real-time CDS
• Care Coordination
• Non-Acute care focus
12. CONFIDENTIAL 12HEALTHCARE GROWTH PARTNERS
High Flyer #1: One Medical Group (http://vimeo.com/62750513)
Series E: $20mm (9/11)
Series F: $30mm (3/13)
Growth Fund: $40 mm (4/14)
Business Model:
Membership based ($149/year), high touch, hi
tech physician practice management serving
multiple and an expanding list of US cities.
Macro Thesis:
A significant care experience and quality gap
exists at most physician practices due to the
underutilization of technology. Payers, patients,
and providers all stand to benefit from IT-enabled
care models.
Opportunities:
1. Strong value prop to payers and patients
2. Savvy physicians may prefer hi-tech practice
3. Risk-based models that align with payers and
employers may be viable once the value
proposition is clearly defined
4. Last valuation 8x revenue!
Threats:
1. Continued acquisition of physician practices
by hospitals and health systems: model may
need to find a way to serve health systems
2. Need to navigate any sensitivity with
standard practices of the AMA
13. CONFIDENTIAL 13HEALTHCARE GROWTH PARTNERS
High Flyer #2: FlatIron Health
Series A: $8mm (10/12)
Series B: $130mm (5/14)
Business Model:
Consolidate disparate structured and
unstructured clinical data into a central EDW for
purpose of driving best practices, cancer
targeting and planning, and drug/treatment
development and optimization.
Macro Thesis:
A specialized analytics play focused exclusively on
cancer that addresses a high cost, high need
segment of healthcare that should align with
stakeholders across cancer care continuum,
including providers, payers, consumers, drug
development and hardware.
Opportunities:
1. Acquired Altos – a cancer-specific EMR, to
streamline the integration with regards to
the data collection process
Threats:
1. Need to overcome aggregation of data from
disparate data sources (EMR, lab, pathology,
imaging, etc) in order to create a longitudinal
care record
2. Unstructured data requires NLP to make it
actionable
3. Data “rights”
4. Can they be EMR-agnostic with Altos?
14. CONFIDENTIAL 14HEALTHCARE GROWTH PARTNERS
High Flyer #3: Health Catalyst (http://vimeo.com/67330845)
Series A: $Undisclosed (9/11)
Series B: $41mm (1/13)
Series C: $41mm (1/14)
Business Model:
Aggregate structured and unstructured data
from disparate data sources and centralize into a
data warehouse that drives actionable and
predictive analytics. (Mostly) Subscription pricing
mitigates upfront cost.
Macro Thesis:
Develop “content-driven clinical applications”
that enable the management of quality measures
and identification of care gaps with an eye
toward value-based reimbursement and a
sensitivity toward physician engagement.
Opportunities:
1. EHR vendors (Epic) leave significant
functionality gaps
2. Coupling EDW w/ quality improvement
3. Value-based pricing lends to ROI proposition
4. Very low penetration of EDW and large
market opportunity – increasing digital data
enhances value-prop
5. Estimated $100mm+ revenue in NTM
Threats:
1. EHR vendors expand (Epic Cogito)
2. Increasingly structured data decreases value
of data aggregation
15. CONFIDENTIAL 15HEALTHCARE GROWTH PARTNERS
High Flyer #4: NantHealth (http://vimeo.com/75977508)
First Round: $25mm (10/12)
Second Round: $100mm (4/14)
Business Model:
Backed by billionaire Patrick Soon-Shiong,
NantHealth aims advance diagnostics to better
identify and target specific disease
characteristics; transform clinical delivery with
clinical data and promoting wellness for a
healthier, happier world by building an
integrated, evidence-based, genomically-
informed, personalized approach to the delivery
of care and the development of next generation
healthcare solutions.
Macro Thesis:
The business model says it all…
Opportunities:
1. Patrick Soon-Shiong has a large brain and
large bank account – having sold two cancer
therapeutic companies (American
Pharmaceutical Partners and Abraxis
BioScience) for an aggregate ~$10B
Threats:
1. Data can only be aggregated and analyzed to
the extent that it can be digitized, and a
finite amount of digital information exists
2. Predicated on the cost curve continuing its
downward trend in sequencing and
personalized medicine
16. CONFIDENTIAL 16HEALTHCARE GROWTH PARTNERS
High Flyer #5: Alignment Healthcare
“Seed”: $125mm (4/14)
Business Model:
A de-novo pop health “start up” (similar to
Evolent) that aims to create alignment between
provider and payer organizations to smooth the
transition to value/risk-based payment models.
Macro Thesis:
Provide technology and integrated care
coordination models to improve quality
outcomes, while lowering cost and eliminating
waste in the care system by focusing on the
highest-cost, most complex patient groups in
Medicare Advantage, Medicaid, and commercial
HMO populations.
Opportunities:
1. Value-based care delivery is the future of
health and healthcare
2. Providers have historically not been in the
business of managing risk, thus are in short
of expertise to make this transition
3. Combo of risk-based, project-based and
subscription pricing model may prove
lucrative
Threats:
1. Large MCO’s are increasingly “owning” the
technology offered by Alignment Healthcare
2. Competitors are coming from all directions
17. CONFIDENTIAL 17HEALTHCARE GROWTH PARTNERS
High Flyer #6: Omada Health (http://vimeo.com/85544572)
Seed: $0.8mm (12/11)
Series A: $4.7mm (3/13)
Series B: $23mm (4/14)
Business Model:
Based on the landmark NIH-sponsored Diabetes
Prevention Program, Prevent provides digital
tracking tools, personalized coaching, and social
support to inspire and sustain healthy behaviors
for consumers, employers, and payers with a
focus on pre-diabetes and the intent to expand
into other treatment programs.
Macro Thesis:
Links the trend toward consumer engagement,
chronic care prevention in high risk populations,
and alignment of stakeholders who
Opportunities:
1. If high-risk populations can be identified and
enrolled, the value proposition is extremely
high across all stakeholders (except those
who earn profits from diabetics)
2. Focus on behavioral change is notoriously
challenging but, once proven hugely
impactful
3. Expansion into other treatment programs
Threats:
1. Requires earning clinical trust
2. Requires payment incentives to align with
outcomes
21. CONFIDENTIAL 21HEALTHCARE GROWTH PARTNERS
Other High Flyers – Consumer Deals
Quality and
Pricing
$7.0mm
The Martin Cos
Operates a Website
that provides users
with the knowledge
and tools they need to
shop for and receive a
fair price for their
healthcare products
and services.
Monitoring
$7.0mm
Samsung Venture
Investment
Corporation and
The Social+Capital
Partnership
Offers blood glucose
monitoring meters .
Fitness
$9.8mm
Mayfield Fund,
Silicon Valley Bank
Owns and operates an
online community for
fitness enthusiasts.
Social
$3.4mm
Adams Street
Partners, 500
Startups,
HealthTech
Capital, Sand Hill
Angels, The
Westly Group
Creators of social
networks specifically
for people with
chronic health
conditions.
Fitness
$250.0mm
Rizvi Traverse
Management
Develops noise
eliminating Bluetooth
headsets and
accessories. App
$2.3mm
Cowboy Ventures;
FLOODGATE;
Google Ventures;
Greylock Partners
A mobile app for
dieting and health.
22. CONFIDENTIAL 22HEALTHCARE GROWTH PARTNERS
Other High Flyers – Consumer Deals
App
$7.0mm
Individual
Investors
Offers RevUp, a
subscription-based
online health
monitoring platform
for population health
management.
Fitness
$50.0mm
Bessemer Venture
Partners,
Institutional
Venture Partners,
Catalyst Investors,
Montreux Equity
Partners and W
Capital Partners
Serves fitness, yoga,
Pilates, salons, spas,
and martial arts
businesses, a software
company, provides
business management
software for personal
service businesses in
the health, wellness,
and beauty industries.
Adherence
$1.5mm
Jonathan Bush,
Tim Draper,
Sabaratnam
Arulkumaran,
Russ Nash, Carl
Byers, James
Nahirny
Owns and operates an
online community for
fitness enthusiasts.
Fitness
$10.5mm
Tiger Global
Management
Provides at-home
fitness solution for live
and on-demand
indoor cycling classes.
App
$5.0mm
Mayo Clinic, The
Social+Capital
Partnership
A personalized health
assistant app.
23. CONFIDENTIAL 23HEALTHCARE GROWTH PARTNERS
Other High Flyers – Provider Deals
Risk
Undisclosed
Health Enterprise
Partners, Heritage
Group
Operates a care
management
company that focuses
on the needs of
patients with chronic
and complex medical
conditions.
Analytics geared
toward value
$41.0mm
CHV Capital,
Kaiser
Permanente
Ventures, Norwest
Venture Partners,
Partners
Innovation Fund,
Sequoia Capital,
Sorenson Capital
Provider of healthcare
data warehousing and
clinical process
analytics.
Outcomes
Undisclosed
Sterling Partners
Outsourced healthcare
outcomes-data
provider focused
exclusively on serving
the quality
departments of acute
care hospitals.
Telehealth
$23.6mm
Heritage Group,
Kayne Anderson
Capital Advisors,
Sentara
Healthcare, Sutter
Health
Corporation
A network of Board
certified physicians
and licensed
therapists, provides
online and on-demand
healthcare delivery
services and software
that benefit patients,
hospitals, employers,
payers, physician
practice groups, and
care organizations.
24. CONFIDENTIAL 24HEALTHCARE GROWTH PARTNERS
Other High Flyers – Provider Deals
Referral
management
$21.0mm
Easton Capital
Investment Group,
New Leaf Venture
Partners, New
Science Ventures,
OrbiMed Advisors,
Reed Elsevier
Ventures, Shasta
Ventures, TELUS
Ventures
Providing secure
mobile messaging
services for healthcare
companies. Telehealth
$32.0mm
Warburg Pincus
Provides specialist
neurologists’ access to
urban, suburban, and
critical access
hospitals through a
consolidated
infrastructure of
people and
videoconferencing
technology.
Referral
management
$35.9mm
Bedford Funding
Offers point-of-care
communications
solutions, including an
iPhone solution for
caregivers that
connects with the
EMR.
Decision support
$12.8mm
Grayhawk Capital,
Kansas Bioscience
Authority
Focuses on translating
the advances in
clinical research into
decision-support
products and services
for physicians and
their patients,
healthcare
organizations, and
other medical
software developers.
25. CONFIDENTIAL 25HEALTHCARE GROWTH PARTNERS
Other High Flyers – Provider Deals
Telehealth
$4.0mm
LionBird
(Ventures),
OrbiMed Advisors
Develops a handheld
device to perform self-
examinations for
remote diagnosis. Adherence
$7.5mm
The West Health
Investment Fund
Offers a rehab
measurement tool to
track patient
adherence for the
prescribed rehab plan.
Analytics geared
toward value
$15.0mm
Accenture (NYSE:
ACN)
Provider of cloud-
based integration and
data management
services and solutions
with funding to
significantly
accelerate its growth
in the life sciences,
healthcare and health
information exchange
(HIE) markets.
Telehealth
$17.0mm
Beta Fund,
Broadview
Ventures,
Launchpad
Venture Group,
Mass Medical
Angels, Safeguard
Scientifics Inc.
(NYSE:SFE)
A cloud-based SaaS
service and wireless
remote patient
monitoring platform.
Decision support
$5.5mm
Draper Triangle,
Hopen Life Science
Ventures, TriStar
Technology
Ventures
Provides automated
workflow, real-time
decision support, and
behavior change
software solutions
that consumers and
businesses use to
change outcomes and
lives.
Chronic
management
$23.0mm
Andreessen
Horowitz, Kaiser
Permanente
Venturesm, The
Vertical Group,
U.S. Venture
Partners
Provides group-based
programs for chronic
disease prevention.
26. CONFIDENTIAL 26HEALTHCARE GROWTH PARTNERS
Other High Flyers – Provider Deals
Population
health
$22.5mm
Great Point
Partners
Offers healthcare
solutions, including
clinical and medical
cost management,
practice and office
management, risk and
financial
management, and
population health
management
solutions
Engagement
$28.7mm
Bpifrance
Financement, Cap
Décisif
Management SAS,
CM-CIC Capital
Innovation,
Innovation Capital
SAS, QUALCOMM
Ventures, Societe
Hospitaliere
D'assurances
Mutuelles,
Vesalius Biocapital
Partners
Voluntis SA provides
software and services
to enable health care
organizations build
and manage patient
relationship
management
programs
Population health
$12.0mm
Harbert Venture
Partners, Noro-
Moseley Partners,
Summit Partners
Provides preventive
care, chronic disease
management, and
health information
exchange systems
IT-enabled care
$40.0mm
Benchmark
Capital; Oak
Investment
Partners; Maverick
Capital, DAG
Ventures, Google
Ventures, Redmile
Group
Operator of primary-
care physician offices
that allow patients to
book same-day visits
online
Provides technology
enabled physician
practices
27. CONFIDENTIAL 27HEALTHCARE GROWTH PARTNERS
Other High Flyers – Provider Deals
Population
health
$125.0mm
General Atlantic
Provides healthcare
services which include
offering care
coordination solution
for population health
management.
Data driven
clinical support &
drug optimization
$100.0mm
Kuwait
Investment
Authority
Provides fiber-optic,
cloud-based data
infrastructure to
deliver multimedia
healthcare
information to mobile
devices.
Referral
management
$54.0mm
Draper Fisher
Jurvetson,
Emergence Capital
Partners,
InterWest
Partners, Morgan
Stanley
Investment
Management,
Morgenthaler, T.
Rowe Price
(NasdaqGS:TROW)
Operates a physician
network platform that
links medical
professionals over the
mobile and Web.
28. CONFIDENTIAL 28HEALTHCARE GROWTH PARTNERS
Other High Flyers – Employer Deals
$12.0mm
Lemhi Ventures,
Timucan Asset
Management
Helps employees
discover and review
benefit options with
ease, as well as offer
tools to help make
complex benefit
concepts and
terminology simple.
$17.1mm
Andreessen
Horowitz,
Maverick Capital,
Ltd., Venrock
Provides payroll and
benefits management,
human resource, and
insurance brokerage
services.
Benefits and HIX
$51.0mm
Great Hill Partners
Offers software and
services that
streamline benefits,
HR, and payroll
administration for
employers, brokers,
and public and private
exchanges.
29. CONFIDENTIAL 29HEALTHCARE GROWTH PARTNERS
Other High Flyers – Life Sciences Deals
Big data
$15.0mm
JAFCO Ventures,
Kleiner Perkins
Caufield & Byers
Develops cloud based
ingestion platform for
drug developers and
researchers. Big data
$4.0mm
Khosla Ventures
Provider of predictive
analytics for medical
science and patient
data.
30. CONFIDENTIAL 30HEALTHCARE GROWTH PARTNERS
Other High Flyers – Payer Deals
Payer Analytics
$15.0mm
Undisclosed
Provides business
process optimization
and intelligence
management
technology solutions
for health insurers’,
commercial,
Medicare, and
Medicaid lines of
business.
Chronic care
management
$40.0mm
Warburg Pincus
Provider of face-to-
face solutions for frail,
special needs and
complex populations,
offering short-term
and long-term care
management and
assessment services
designed to improve
quality outcomes,
optimize revenue, and
lower costs.
Benefits Mgmt
Undisclosed
General Atlantic
Provides evidence-
based healthcare
management
programs. HIX
$35.0mm
Undisclosed
Offers solutions that
enable consumers and
businesses to connect,
communicate, and
engage with health
plans for acquiring
health insurance.
HIX
$10.5mm
Aberdare
Ventures,
FirstMark Capital
An online health
insurance
marketplace.
31. CONFIDENTIAL 31HEALTHCARE GROWTH PARTNERS
Technology-Enabled Healthcare Delivery – Who to watch?
Humedica (2013), Connextions
(2011), Ventures Group
Coventry (2012), Healthagen
(2011), Prodigy (2011),
Medicity (2010)
Linkwell (2013), Amerigroup
(2012), SoloHealth (2012),
Bloom (2011), CareMore
(2011), HealthyCare Solutions
Certify Data (2012), Anvita
(2011), Concentra (2010)
PureWellness (2013), Clairvia
(2011), Resource Systems
(2011), IMC Health (2009)
Medical Referral (2013),
360Fresh (2012), Pivot Health &
Cielo Med (2011), Southwind
(2010), Crimson (2008)
Array (2013), $11mm Carnegie
Mellon Partnership, $100mm
Medical Mall
Data warehouse initiative,
UPMC Health Plan
CardioCom (2013)
Health Catalyst, Telcare,
AssureRx, Airstrip
Navihealth, Hello Health,
Patientco, change:healthcare,
Essence Group, Bloom Health,
Phreesia
Quantros, Navihealth, Vivify,
GetWellNetwork, BodyMedia,
Phreesia
Aviacode, Vivify, Awarepoint,
Shareable Ink
Transparent Insurance ($40mm
investment in July ‘13)
35mm member “transparent”
PBM
Competitive Dynamics
Oscar Health